COCP READ THE FULL COCP RESEARCH REPORT Business Update Presentation at ICAR 2026 Showcases CDI-988 On April 30, 2026, ...

On April 2, 2026, Cocrystal Pharma, Inc. (NASDAQ: COCP) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CDI-988, the company’s pan-viral protease ...

A recent norovirus outbreak aboard the Caribbean Princess cruise ship has once again highlighted how quickly this highly contagious stomach virus can spread. Here's everything to know about norovirus, ...

Add Yahoo as a preferred source to see more of our stories on Google. Emergency rooms and urgent cares are seeing an increase of people being diagnosed with norovirus. This highly contagious virus is ...

BOTHELL, Wash., March 09, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces the first subjects have been dosed in a Phase 1b norovirus challenge ...

Detailed price information for Cocrystal Pharma Inc (COCP-Q) from The Globe and Mail including charting and trades.

Subject enrollment expected to begin in Q1 2026 CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral ...

Norovirus, a highly contagious virus, is spreading across the US, with wastewater data indicating rising cases. Health ...

Norovirus, the infamous "winter vomiting disease," is surging again across the United States. Norovirus is a highly contagious stomach bug that causes sudden, often violent bouts of diarrhea and ...

Completed enrollment in first cohort of Phase 1b challenge study evaluating CDI-988 as a preventive and as a treatment for ...

Laura Leavitt is a personal finance and wellness writer for CNET. Her work has been published at NextAdvisor, Bankrate, The Simple Dollar, MoneyGeek, Business Insider and more. Norovirus outbreaks are ...